Download Library
| Interim Report for the First Quarter 2018 | Download |
| Genmab First Quarter 2018 Results Presentation | Download |
| Genmab IR Presentation_9May18 | Download |
| Kempen Life Sciences Conference - April 2018 | Download |
| AGM 2018 Presentation | Download |
| Articles of Association dated February 28, 2018 | Download |
| Statutory Corporate Governance Report 2017 | Download |
| Election Results of the Annual General Meeting 2018 | Download |
| J.P. Morgan Healthcare Conference - January 2018 | Download |
| Investor Presentation, January 2018 | Download |
| Genmab 2017 Annual Report | Download |
| Full Year 2017 Results Presentation | Download |
| Statutory Report on Corporate Social Responsibility 2017 | Download |
| Genmab's 2017 R&D Update - December 2017 | Download |
| Citi 2017 Global Healthcare Conference - December 2017 | Download |
| Jefferies London Healthcare Conference, London, UK | Download |
| Interim Report for the First Nine Months of 2017 | Download |
| A Phase IIa Study of Tisotumab Vedotin (HuMax®-TF-ADC) in Patients With Relapsed, Recurrent and/or Metastatic Cervical Cancer: Updated Safety and Efficacy – ESGO E-poster – November 2017 (Concin) | Download |
| Genmab First Nine Months of 2017 Results Presentation | Download |
| Investor Presentation, September 2017 | Download |
| Interim Report for the First Half 2017 | Download |
| Genmab First Half 2017 Results Presentation | Download |
| Interim Report for the First Quarter 2017 | Download |
| 10th Kempen & Co. Life Science Conference - April 2017 | Download |
| AGM 2017 Presentation | Download |
| Genmab Q1 2017 Results Presentation | Download |